← Open Payments lookup

LAKSHIKA RANAWEERA: Open Payments

NPI 1285830653 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$651 in 25 payments from 9 companies in 2025. Trend: 2023 $118 · 2024 $135 · 2025 $651

Food & beverage: $651
CompanyPaymentsAmount
ABBVIE INC.5$172
Alkermes, Inc.5$111
Janssen Pharmaceuticals, Inc2$102
Otsuka America Pharmaceutical, Inc.4$100
Takeda Pharmaceuticals U.S.A., Inc.3$54
Lundbeck LLC3$53
Vanda Pharmaceuticals Inc.1$27
E.R. Squibb & Sons, L.L.C.1$16
Bard Peripheral Vascular, Inc.1$16

Products named: REXULTI, VRAYLAR, ARISTADA, SPRAVATO, TRINTELLIX, FANAPT, CAMZYOS, Venovo.

Industry payments across KS — which companies pay providers there.